| Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial M Castella, M Caballero-Baños, V Ortiz-Maldonado, ... Frontiers in Immunology 11, 482, 2020 | 125 | 2020 |
| Preclinical development of a humanized chimeric antigen receptor against B-cell maturation antigen for multiple myeloma L Perez-Amill, G Suñe, A Antoñana-Vildosola, M Castella, A Najjar, ... Haematologica 106 (1), 173, 2021 | 37 | 2021 |
| Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate E Prieto-Fernández, L Egia-Mendikute, L Vila-Vecilla, A Bosch, ... Emerging Microbes & Infections 10 (1), 1065-1076, 2021 | 31 | 2021 |
| Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b MP Lenza, L Egia-Mendikute, A Antoñana-Vildosola, CO Soares, ... Nature Communications 14 (1), 3496, 2023 | 19 | 2023 |
| Hypoxia promotes syndecan-3 expression in the tumor microenvironment E Prieto-Fernández, L Egia-Mendikute, A Bosch, A García del Río, ... Frontiers in immunology 11, 586977, 2020 | 19 | 2020 |
| Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals L Egia-Mendikute, A Bosch, E Prieto-Fernández, SY Lee, ... Communications biology 4 (1), 486, 2021 | 18 | 2021 |
| Extracellular NK histones promote immune cell anti-tumor activity by inducing cell clusters through binding to CD138 receptor B Martín-Antonio, G Suñe, A Najjar, L Perez-Amill, A Antoñana-Vildosola, ... Journal for immunotherapy of cancer 7, 1-16, 2019 | 12 | 2019 |
| Enabling CAR-T cells for solid tumors: Rage against the suppressive tumor microenvironment. A Antoñana-Vildosola, SR Zanetti, A Palazon International Review of Cell and Molecular Biology 370, 123-147, 2022 | 11 | 2022 |
| A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants L Egia-Mendikute, A Bosch, E Prieto-Fernández, L Vila-Vecilla, SR Zanetti, ... Frontiers in immunology 13, 1014309, 2022 | 6 | 2022 |
| Factor inhibiting HIF (FIH) promotes lung cancer progression A García-del Río, E Prieto-Fernández, L Egia-Mendikute, ... JCI insight, 2023 | 3 | 2023 |
| Co-Transduced CD19/BCMA Dual-Targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma M Bachiller, C Dobaño-López, A Rodríguez-García, J Castellsagué, ... Blood 140 (Supplement 1), 7386-7387, 2022 | 2 | 2022 |
| Engineering BCMA-CAR T cells to overcome CD19-negative relapse in B cell non-Hodgkin lymphomas A Antonana-Vildosola, L Perez-Amill, G Sune, M Castella, A Najjar, ... HUMAN GENE THERAPY 30 (11), A67-A68, 2019 | | 2019 |
| Development of an efficient transduction protocol for CAR-19 in cord blood derived-NK cells L Perez-Amill, G Sune, A Antonana-Vildosola, A Najjar, M Castella, ... HUMAN GENE THERAPY 30 (11), A72-A72, 2019 | | 2019 |
